The evaluation of liver fibrosis regression in chronic hepatitis C patients after the treatment with direct-acting antiviral agents – A review of the literature

The evaluation of liver fibrosis regression in chronic hepatitis C patients after the treatment with direct-acting antiviral agents – A review of the literature

The second-generation of direct-acting antiviral agents are the current treatment for chronic viral hepatitis C infection. To evaluate the regression of liver fibrosis in patients receiving this therapy, liver biopsy remains the most accurate method, but the invasiveness of this procedure is its maj...

Full description

Saved in:
Bibliographic Details
Main Authors: Olga H. Orasan, George Ciulei, Sorina C. Coste, Bianca A. Cibu, Adela V. Sitar Taut, Simina F. Tarmure, Iulia O. Pfingstgraf, Teodora G. Alexescu, Ionela E. Popovici, Flaviu Mureșan, Fabian Ovidiu, Vasile Negrean, Angela Cozma
Format: Article
Language:English
Published: MDPI AG 2019-10-01
Series:Journal of Mind and Medical Sciences
Subjects:
chronic viral hepatitis C
direct-acting antiviral agents
liver fibrosis
Online Access:https://scholar.valpo.edu/cgi/viewcontent.cgi?article=1191&context=jmms
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://scholar.valpo.edu/cgi/viewcontent.cgi?article=1191&context=jmms

Similar Items